No trading action warranted. This is a routine proxy notice with standard proposals. Monitor the actual proxy statement for any compensation changes or governance updates that could affect shareholder voting.
BIIB drugs
BIIB drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Apr 29 $194.34entry
- T+1 · 7mo ago −2.57%α −3.59% · $189.35
- T+5 · 7mo ago −2.15%α −5.26% · $190.17
- T+20 · 6mo ago +0.78%α −5.27% · $195.86
- T+60 · 4mo ago +3.23%α −0.51% · $200.62
Price Chart
How similar events traded
Executive Summary
Biogen filed a DEFA14A (additional definitive proxy soliciting materials) providing notice of its 2026 Annual Meeting to be held on June 9, 2026. The filing outlines standard proposals: election of 10 director nominees, ratification of PricewaterhouseCoopers as auditor, and an advisory vote on executive compensation. This is a routine administrative filing with no material financial information or activist campaign content.
Key Financial Metrics
Key Facts
- Annual Meeting scheduled for June 9, 2026 at 9:00 AM ET, virtual format
- Board recommends voting FOR all 10 director nominees
- Board recommends voting FOR ratification of PricewaterhouseCoopers as auditor for FY2026
- Board recommends voting FOR advisory say-on-pay proposal
- Voting deadline is June 8, 2026 at 11:59 PM ET
- Proxy materials include 2026 Notice and Proxy Statement and 2025 Annual Report/Form 10-K
Financial Impact
No financial figures disclosed in this filing
Risk Factors
- No material risks identified from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-187383 |
| Document: 0001193125-26-187383-index-headers.html | 0001193125-26-187383 |
| Document: 0001193125-26-187383-index.html | 0001193125-26-187383 |
| Document: 0001193125-26-187383.txt | 0001193125-26-187383 |
Track record
34 reports on BIIB
10 of 12 bullish or bearish reports moved the stock their way by T+60. Best: +15.73% at T+60 after the Jul 13, 2026 report. 16 of 17 went positive at some point.
Filters
- Nov 12, 20264d ago Press Release Neutral 3/10 Entry $253.40 Now $251.65 −0.69% settles Feb 11
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $253.25 Now $251.65 −0.63% settles Feb 8
- Nov 9, 20267d ago Press Release Neutral 4/10 Entry $254.87 Now $251.65 −1.26% settles Feb 5
- Oct 28, 202619d ago Institutional Cluster Neutral 2/10 Entry $244.05 Now $251.65 +3.11% settles Jan 26
- Oct 28, 202619d ago 8-K Bullish 6/10 Entry $244.05 Now $251.65 +3.11% settles Jan 26
- Oct 19, 202628d ago Press Release Neutral 4/10 Entry $233.48 Now $251.65 +7.78% settles Jan 14
- Oct 12, 20265w ago ANALYST-UPGRADE Bullish 6/10 Entry $229.41 Now $251.65 +9.69% settles Jan 7
- Oct 2, 20266w ago Press Release Bullish 6/10 Entry $219.88 Now $251.65 +14.45% settles Dec 29
- Sep 17, 20268w ago Press Release Bullish 5/10 Entry $215.50 Now $251.65 +16.77% settles Dec 14
- Sep 3, 202610w ago Press Release Neutral 4/10 Entry $220.83 Now $251.65 +13.96% settles Dec 1
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers